World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
11223
World Ranking
3352
National Ranking
1551

David W. Scott publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David W. Scott sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 359 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David W. Scott D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Scott sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David W. Scott is affiliated with the Uniformed Services University of the Health Sciences in the United States. Their research intersects multiple areas within Medicine, spanning 97 publications that contribute to various subfields including Pathology and Forensic Medicine, Immunology, Oncology, Genetics, and Hematology.

Their recent work features papers published between 2020 and 2021 covering topics such as immune regulation, infectious diseases, and molecular diagnostics. Notable recent papers include:

  • Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR (2020, Scientific Reports)
  • Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression (2020, Cellular Immunology)
  • Tolerating Factor VIII: Recent Progress (2020, Frontiers in Immunology)
  • Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor (2020, Cellular Immunology)
  • Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers (2021, BMC Infectious Diseases)

David W. Scott frequently collaborates with a core group of coauthors, including Kerry J. Savage, Diego Villa, Alina S. Gerrie, Laurie H. Sehn, and Pedro Farinha, with collaboration counts ranging from 13 to 18 publications per individual.

Their work appears predominantly in specialized journals and venues aligned with hematology and immunology. Frequent publication venues include:

  • Blood
  • Cellular Immunology
  • Frontiers in Immunology
  • Haematologica
  • UNC Libraries

Their research topics cover a wide scope within immune and hematologic diseases, with particular focus on:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • CNS Lymphoma Diagnosis and Treatment
  • Hemophilia Treatment and Research
  • T-cell and B-cell Immunology

David W. Scott's contributions reflect a blend of clinical and translational studies addressing immune cell dynamics, hematologic malignancies, and the application of engineered immunotherapies.

Best Publications

  • Immunogenicity of protein therapeutics

    Anne S. De Groot;David W. Scott

  • Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance

    Roberto A. Maldonado;Robert A. LaMothe;Joseph D. Ferrari;Ai-Hong Zhang

  • Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

    Anne S. De Groot;Leonard Moise;Julie A. McMurry;Erik Wambre

  • Activation-induced apoptosis in lymphocytes.

    Douglas R. Green;David W. Scott

  • Death the Fas way: regulation and pathophysiology of CD95 and its ligand.

    K Sharma;R.X Wang;L.Y Zhang;D.L Yin

  • Regulation of the G1 phase of the mammalian cell cycle

    Dubravka Donjerkovic;David W Scott

  • Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins

    Tie Chi Lei;David W. Scott

  • Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses.

    Yong Chan Kim;Ai-Hong Zhang;Yan Su;Sadiye Amcaoglu Rieder

  • FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII.

    Jeongheon Yoon;Anja Schmidt;Ai-Hong Zhang;Christoph Königs

  • Tregitope update: Mechanism of action parallels IVIg

    Leslie P. Cousens;Ryan Tassone;Bruce D. Mazer;Vasanthi Ramachandiran

  • Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.

    David W. Scott;Daniella Livnat;Christopher A. Pennell;Christopher A. Pennell;Peter Keng

  • Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.

    Gavin Fischer;Sally C. Kent;Luc Joseph;Doughs R. Green

  • In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity

    Leslie P. Cousens;Nader Najafian;Federico Mingozzi;Wassim Elyaman

  • Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis

    Rajeev K. Agarwal;Yubin Kang;Elias Zambidis;David W. Scott

  • Role of IgD in the immune response and tolerance. I. Anti-delta pretreatment facilitates tolerance induction in adult B cells in vitro.

    D W Scott;J E Layton;G J Nossal

  • Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases.

    Marco E. F. Melo;Jiahua Qian;Moustapha El-Amine;Rajeev K. Agarwal

  • Activation-induced cell death in B lymphocytes.

    Dubravka DONJERKOVIć;David W Scott

  • T cells commit suicide, but B cells are murdered!

    D. W. Scott;T. Grdina;Yufang Shi

  • Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes

    Deborah M. Brown;Garvin L. Warner;JoséE. Alés-Martínez;David W. Scott

  • Epitope-specific tolerance induction with an engineered immunoglobulin

    Elias T. Zambidis;David W. Scott

  • Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.

    Yong Chan Kim;Ai-Hong Zhang;Jeongheon Yoon;William E. Culp

Frequent Co-Authors

Anne S. De Groot
Anne S. De Groot University of Georgia
Richard P. Phipps
Richard P. Phipps University of Rochester
William J. Martin
William J. Martin National Institutes of Health
Federico Mingozzi
Federico Mingozzi Children's Hospital of Philadelphia
Yufang Shi
Yufang Shi Soochow University
Douglas R. Green
Douglas R. Green St. Jude Children's Research Hospital
Rachel R. Caspi
Rachel R. Caspi National Institutes of Health
Samia J. Khoury
Samia J. Khoury American University of Beirut
Ethan M. Shevach
Ethan M. Shevach National Institute of Allergy and Infectious Diseases
Omid C. Farokhzad
Omid C. Farokhzad Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to a variety of specialized healthcare careers, including advanced nursing roles. Many professionals interested in integrating immunology with patient care pursue online options to enhance their credentials. For instance, the best pmhnp programs online focus on psychiatric-mental health nursing, a field closely linked with immunological studies on neuroimmune interactions.

Affordability is a key concern for students balancing education with work. Exploring the cheapest pmhnp programs online can provide cost-effective pathways to gain specialized knowledge and clinical skills. These programs often offer flexible schedules, making them ideal for working healthcare professionals.

Career progression after earning advanced degrees is another important consideration. Understanding how much do dnps make highlights the financial benefits that can come with completing a Doctor of Nursing Practice (DNP), especially in immunology-informed specialties.

For nurses looking to diversify their expertise, resources on how to transition, such as from fnp to acute care np, provide valuable guidance. Combining immunology knowledge with acute care skills can lead to impactful patient outcomes and rewarding career growth.

Best Scientists Citing David W. Scott

Trending Scientists

Recently Published Articles